201 related articles for article (PubMed ID: 28097536)
1. Prevalence and correlates of ADHD in individuals with substance use disorder in Nigeria.
Umar MU; Salihu AS; Owolabi SD
Atten Defic Hyperact Disord; 2017 Sep; 9(3):189-198. PubMed ID: 28097536
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
[TBL] [Abstract][Full Text] [Related]
3. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.
van Emmerik-van Oortmerssen K; van de Glind G; Koeter MW; Allsop S; Auriacombe M; Barta C; Bu ET; Burren Y; Carpentier PJ; Carruthers S; Casas M; Demetrovics Z; Dom G; Faraone SV; Fatseas M; Franck J; Johnson B; Kapitány-Fövény M; Kaye S; Konstenius M; Levin FR; Moggi F; Møller M; Ramos-Quiroga JA; Schillinger A; Skutle A; Verspreet S; ; van den Brink W; Schoevers RA
Addiction; 2014 Feb; 109(2):262-72. PubMed ID: 24118292
[TBL] [Abstract][Full Text] [Related]
5. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria.
van de Glind G; Konstenius M; Koeter MWJ; van Emmerik-van Oortmerssen K; Carpentier PJ; Kaye S; Degenhardt L; Skutle A; Franck J; Bu ET; Moggi F; Dom G; Verspreet S; Demetrovics Z; Kapitány-Fövény M; Fatséas M; Auriacombe M; Schillinger A; Møller M; Johnson B; Faraone SV; Ramos-Quiroga JA; Casas M; Allsop S; Carruthers S; Schoevers RA; Wallhed S; Barta C; Alleman P; ; Levin FR; van den Brink W
Drug Alcohol Depend; 2014 Jan; 134():158-166. PubMed ID: 24156882
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in substance use disorder patients with and without attention deficit hyperactivity disorder 12 months after treatment: a naturalistic follow-up study.
Flores-García L; Lensing MB; Ytterstad E; Eisemann M
Atten Defic Hyperact Disord; 2019 Sep; 11(3):299-310. PubMed ID: 30903585
[TBL] [Abstract][Full Text] [Related]
7. Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults.
Young JT; Carruthers S; Kaye S; Allsop S; Gilsenan J; Degenhardt L; van de Glind G; van den Brink W; Preen D
Drug Alcohol Rev; 2015 Nov; 34(6):683-93. PubMed ID: 25790353
[TBL] [Abstract][Full Text] [Related]
8. The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population.
van de Glind G; Van Emmerik-van Oortmerssen K; Carpentier PJ; Levin FR; Koeter MW; Barta C; Kaye S; Skutle A; Franck J; Konstenius M; Bu ET; Moggi F; Dom G; Demetrovics Z; Fatséas M; Schillinger A; Kapitány-Fövény M; Verspreet S; Seitz A; Johnson B; Faraone SV; Ramos-Quiroga JA; Allsop S; Carruthers S; Schoevers RA; ; van den Brink W
Int J Methods Psychiatr Res; 2013 Sep; 22(3):232-44. PubMed ID: 24022983
[TBL] [Abstract][Full Text] [Related]
9. Early-age clinical and developmental features associated to Substance Use Disorders in Attention-Deficit/Hyperactivity Disorder in Adults.
Nogueira M; Bosch R; Valero S; Gómez-Barros N; Palomar G; Richarte V; Corrales M; Nasillo V; Vidal R; Casas M; Ramos-Quiroga JA
Compr Psychiatry; 2014 Apr; 55(3):639-49. PubMed ID: 24411652
[TBL] [Abstract][Full Text] [Related]
10. Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice.
Clure C; Brady KT; Saladin ME; Johnson D; Waid R; Rittenbury M
Am J Drug Alcohol Abuse; 1999 Aug; 25(3):441-8. PubMed ID: 10473007
[TBL] [Abstract][Full Text] [Related]
11. Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms.
Kaye S; Gilsenan J; Young JT; Carruthers S; Allsop S; Degenhardt L; van de Glind G; van den Brink W
Drug Alcohol Depend; 2014 Nov; 144():70-7. PubMed ID: 25193717
[TBL] [Abstract][Full Text] [Related]
12. A Cross-sectional Cohort Study of Prevalence, Co-Morbidities, and Correlates of Attention-deficit Hyperactivity Disorder among Adult Patients Admitted to the Li Ka Shing Psychiatric Outpatient Clinic, Hong Kong.
Leung VM; Chan LF
East Asian Arch Psychiatry; 2017 Jun; 27(2):63-70. PubMed ID: 28652499
[TBL] [Abstract][Full Text] [Related]
13. Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders.
Sánchez-García NC; González RA; Ramos-Quiroga JA; van den Brink W; Luderer M; Blankers M; Grau-Lopez L; Levin FR; Kaye S; Demetrovics Z; van de Glind G; Schellekens A; Vélez-Pastrana MC;
Eur Addict Res; 2020; 26(4-5):191-200. PubMed ID: 32564016
[TBL] [Abstract][Full Text] [Related]
14. Substance use disorder and ADHD: is ADHD a particularly "specific" risk factor?
Kousha M; Shahrivar Z; Alaghband-Rad J
J Atten Disord; 2012 May; 16(4):325-32. PubMed ID: 22127397
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.
Wilens TE; Kwon A; Tanguay S; Chase R; Moore H; Faraone SV; Biederman J
Am J Addict; 2005; 14(4):319-27. PubMed ID: 16188712
[TBL] [Abstract][Full Text] [Related]
16. Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder.
Vilar-Ribó L; Sánchez-Mora C; Rovira P; Richarte V; Corrales M; Fadeuilhe C; Arribas L; Casas M; Ramos-Quiroga JA; Ribasés M; Soler Artigas M
Am J Med Genet B Neuropsychiatr Genet; 2021 Apr; 186(3):140-150. PubMed ID: 33244849
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing ADHD during active substance use: Feasible or flawed?
van Emmerik-van Oortmerssen K; Vedel E; Kramer FJ; Koeter MW; Schoevers RA; van den Brink W
Drug Alcohol Depend; 2017 Nov; 180():371-375. PubMed ID: 28957778
[TBL] [Abstract][Full Text] [Related]
18. Impact of substance use disorder on ADHD and its treatment.
Wilens TE; Upadhyaya HP
J Clin Psychiatry; 2007 Aug; 68(8):e20. PubMed ID: 17876905
[TBL] [Abstract][Full Text] [Related]
19. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
[TBL] [Abstract][Full Text] [Related]
20. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility.
Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K
Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
